Literature DB >> 15695150

Comparison of the strain Doppler echocardiographic features of familial amyloid polyneuropathy (FAP) and light-chain amyloidosis.

Fumiaki Ogiwara1, Jun Koyama, Shu-Ichi Ikeda, Osamu Kinoshita, Rodney H Falk.   

Abstract

Previous work has demonstrated that familial amyloid polyneuropathy (FAP) and light-chain amyloidosis with similar degrees of cardiac involvement cannot be distinguished by standard echocardiographic parameters, yet the severity of congestive heart failure and cardiac mortality is much less in FAP. It was therefore hypothesized that strain and strain-rate imaging, sensitive markers of longitudinal systolic dysfunction, might detect a difference in left ventricular function between FAP and light-chain amyloidosis that could account for the clinical differences.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15695150     DOI: 10.1016/j.amjcard.2004.10.029

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  10 in total

Review 1.  Use of tissue Doppler imaging to identify and manage systemic diseases.

Authors:  Frank Weidemann; Joerg M Strotmann
Journal:  Clin Res Cardiol       Date:  2007-08-29       Impact factor: 5.460

Review 2.  Strain imaging in echocardiography: methods and clinical applications.

Authors:  Gillian C Nesbitt; Sunil Mankad; Jae K Oh
Journal:  Int J Cardiovasc Imaging       Date:  2009-01-15       Impact factor: 2.357

3.  Role of echocardiography in assessing cardiac amyloidoses: a systematic review.

Authors:  Jun Koyama; Masatoshi Minamisawa; Yoshiki Sekijima; Koichiro Kuwahara; Tsutomu Katsuyama; Kazutoshi Maruyama
Journal:  J Echocardiogr       Date:  2019-02-11

4.  Differentiation of light-chain cardiac amyloidosis from hypertrophic cardiomyopathy using myocardial mechanical parameters by velocity vector imaging echocardiography.

Authors:  Lu Zhang; Xiao Zhou; Jing Wang; Yang Mu; Bohan Liu; Wenqing Lv; Ye Wang; Hongwei Liu; Hongbin Liu; Guang Zhi
Journal:  Int J Cardiovasc Imaging       Date:  2016-11-23       Impact factor: 2.357

5.  Cardiac amyloidosis: A new challenge of multimodality imaging.

Authors:  Carmela Nappi; Roberta Assante; Emilia Zampella; Alberto Cuocolo
Journal:  J Nucl Cardiol       Date:  2018-06-26       Impact factor: 5.952

6.  Pressure-volume relationships in patients with transthyretin (ATTR) cardiac amyloidosis secondary to V122I mutations and wild-type transthyretin: Transthyretin Cardiac Amyloid Study (TRACS).

Authors:  Taslima Bhuiyan; Stephen Helmke; Ayan R Patel; Frederick L Ruberg; Jeff Packman; Kin Cheung; Donna Grogan; Mathew S Maurer
Journal:  Circ Heart Fail       Date:  2010-12-29       Impact factor: 8.790

Review 7.  Use of Noninvasive Imaging in Cardiac Amyloidosis.

Authors:  Raymundo Alain Quintana-Quezada; Syed Wamique Yusuf; Jose Banchs
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-07

Review 8.  Multidisciplinary Approaches for Transthyretin Amyloidosis.

Authors:  Haruki Koike; Takahiro Okumura; Toyoaki Murohara; Masahisa Katsuno
Journal:  Cardiol Ther       Date:  2021-06-04

9.  Left ventricular deformation and torsion assessed by speckle-tracking echocardiography in patients with mutated transthyretin-associated cardiac amyloidosis and the effect of diflunisal on myocardial function.

Authors:  Jun Koyama; Masatoshi Minamisawa; Yoshiki Sekijima; Shu-Ichi Ikeda; Ayako Kozuka; Soichirou Ebisawa; Takashi Miura; Hirohiko Motoki; Ayako Okada; Atsushi Izawa; Uichi Ikeda
Journal:  Int J Cardiol Heart Vasc       Date:  2015-08-04

10.  Updates in cardiac amyloidosis: a review.

Authors:  Sanjay M Banypersad; James C Moon; Carol Whelan; Philip N Hawkins; Ashutosh D Wechalekar
Journal:  J Am Heart Assoc       Date:  2012-04-24       Impact factor: 5.501

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.